|
Realtime-Estimate
Tradegate
14:38:34 05.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 87.30 EUR | +0.97% |
|
-2.68% | -18.02% |
| 02.10. | Schwacher Arbeitsmarkt gibt Aktien Auftrieb |  |
| 02.10. | Grails Bluttest zur Krebserkennung nähert sich wichtiger FDA-Zulassung, doch Versicherungsschutz bleibt offen | RE |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.84% | -3.74% | -10.00% | +2.20% | -22.18% | -27.56% | +1.93% | -15.61% | +131.59% | 169 Mrd. | |
| -0.07% | -2.55% | -8.27% | +3.83% | -10.08% | -11.59% | +13.26% | -30.92% | +0.31% | 110 Mrd. | |
| +0.90% | +1.13% | -9.14% | -15.65% | -21.63% | -25.66% | +3.47% | +4.99% | +136.91% | 106 Mrd. | |
| +1.54% | -0.75% | -2.39% | -15.99% | -46.28% | -47.48% | -11.04% | -13.68% | +27.64% | 73.87 Mrd. | |
| -0.24% | +0.69% | -6.62% | +4.23% | -8.50% | +2.08% | +69.19% | +161.18% | +283.77% | 58.98 Mrd. | |
| +1.32% | +3.86% | +1.47% | -4.20% | +3.44% | +8.58% | +61.88% | +53.32% | +484.45% | 51.28 Mrd. | |
| -0.71% | -3.82% | -4.30% | +11.84% | -8.90% | -8.68% | -31.93% | -26.50% | +0.41% | 48.16 Mrd. | |
| +0.12% | -0.17% | -3.17% | -7.07% | -23.38% | -17.87% | +19.66% | -15.60% | +359.04% | 40.84 Mrd. | |
| -1.01% | -1.45% | -2.89% | +19.80% | +28.61% | +27.31% | -2.67% | -35.14% | +316.75% | 32.21 Mrd. | |
| +1.92% | +2.62% | -2.68% | -17.55% | -15.21% | - | - | - | - | 31.24 Mrd. | |
| +0.38% | -1.12% | -6.92% | -3.49% | -16.21% | -13.79% | -22.73% | -27.07% | - | 30.8 Mrd. | |
| -0.01% | -1.47% | +7.36% | -0.21% | +32.65% | +33.91% | -2.35% | -10.94% | +398.27% | 25.69 Mrd. | |
| +1.75% | +0.31% | +10.15% | +5.85% | +74.07% | +182.94% | +530.50% | +67.78% | - | 23.86 Mrd. | |
| +0.86% | -3.05% | +12.60% | +17.06% | 0.00% | +5.87% | -7.24% | -53.69% | +219.15% | 22.8 Mrd. | |
| +1.78% | -0.26% | -3.79% | -0.44% | +0.59% | -10.87% | +17.55% | -7.92% | +131.83% | 20.98 Mrd. | |
| -0.38% | -0.19% | -7.15% | -4.43% | -17.74% | -14.00% | -6.30% | +1.22% | +191.50% | 20.33 Mrd. | |
| +2.05% | +1.44% | +9.31% | +22.28% | +22.45% | +14.39% | +19.68% | -26.94% | +82.71% | 17.79 Mrd. | |
| +2.07% | -5.31% | -1.83% | -15.72% | -2.29% | +2.03% | -20.14% | -45.63% | +135.36% | 17.27 Mrd. | |
| +0.26% | -3.02% | -9.97% | +0.94% | -1.81% | -12.39% | -19.51% | -39.83% | -31.68% | 16.84 Mrd. | |
| Durchschnitt | +0.62% | -1.02% | -2.01% | +0.17% | -1.70% | +4.84% | +34.07% | -3.39% | +179.25% | 48.3 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.32% | -1.20% | -4.71% | -1.28% | -10.60% | -8.28% | +21.91% | -0.16% | +156.71% |
- Börse
- Aktien
- 850103 Aktie
- 850103 Aktie
- Sektor Abbott Laboratories
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
